Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Phase 2 data published in the New England Journal of Medicine in 2023 showed that the 12 mg dose produced a mean 24.2% reduction in body weight at 48 weeks in adults with obesity, which is numerically larger than anything reported for a single agent in a controlled trial to that point
Exenatide was solely responsible for this effect
Injectables are typically administered less frequently as well, for example, weekly, whereas pills are often taken on a daily basis
*Correspondence: Zijie Li, [email protected] This article was submitted to Food Microbiology, a section of the journal Frontiers in Microbiology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
&srotate=0)
